P

Phathom Pharma (PHAT)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Phathom Pharma (PHAT)

Phathom Pharmaceuticals, Inc. is a late clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing treatments for gastrointestinal (GI) diseases. Its product candidate, vonoprazan, is an oral small molecule pot... Read more

  • 9.51
  • 9.66
  • 9.04
  • 20.30
  • -9.2%
  • --
  • 107.31k
  • 127.55k
  • 397M
  • 6.10
  • -54.2%
  • %

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.